Effect of exposure to fluoroquinolones and beta-lactams on the in vitro activity of other groups of antibiotics in Salmonella spp.

APMIS

Volumn 114, Issue 7-8, 2006, Pages 523-528

  Cebrian, Laura ^a   Rodríguez, Juan Carlos ^a   Escribano, Isabel ^a   Royo, Gloria ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

Beta lactams; Fluoroquinolones; Resistance; Salmonella

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FOSFOMYCIN; GATIFLOXACIN; IMIPENEM; MOXIFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; TOBRAMYCIN; TROVAFLOXACIN;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; BACTERIUM MUTANT; DRUG ACTIVITY; DRUG EFFECT; GENE MUTATION; GENETIC SUSCEPTIBILITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SALMONELLOSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; MUTATION; SALMONELLA;

EID: 33747391149     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_357.x     Document Type: Article

References (30)

1. Parry CM. Antimicrobial drug resistance in Salmonella enterica. Curr Opin Infect Dis 2003;16:467-72.
2. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis 2001;32:263-9.
3. Ruiz M, Rodriguez JC, Escribano I, Royo G. Available options in the management of non-typhi Salmonella. Expert Opin Pharmacother 2004;5:1737-43.
4. Threlfall EJ, Fisher IS, Berghold C, Gerner-Smidt P, Tschape H, Cormican M, et al. Antimicrobial drug resistance in isolates of Salmonella enterica from cases of salmonellosis in humans in Europe in 2000: results of international multi-centre surveillance. Euro Surveill 2003;8:41-5.
5. Leegaard TM, van Gestel MH, Petit PL, van de Klundert JA. Antibiotic resistance mechanisms in Salmonella species causing bacteraemia in Malawi and Kenya. APMIS 1996;104:302-6.
6. Aarestrup FM, Bager F, Jensen NE, Madsen M, Meyling A, Wegener HC. Surveillance of antimicrobial resistance in bacteria isolated from food animals to antimicrobial growth promoters and related therapeutic agents in Denmark. APMIS 1998;106:606-22.
7. Ruiz M, Rodriguez JC, Sirvent E, Escribano I, Cebrian L, Royo G. Usefulness of different techniques in the study of the epidemiology of salmonellosis. APMIS 2003;111:848-56.
8. Cebrián L, Sirvent E, Rodriguez Diaz JC, Ruiz M, Royo G. Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int J Antimicrob Agents 2003;22:134-9.
9. Cebrián L, Rodríguez JC, Escribano I, Royo G. Characterization of Salmonella spp. mutants with reduced fluoroquinolone susceptibility: importance of efflux pump mechanisms. Chemotherapy 2005;51:40-3.
10. Escribano I, Rodríguez JC, Cebrián L, Royo G. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int J Antimicrob Agents 2004;24:428-32.
11. Koutsolioutsou A, Martins EA, White DG, Levy SB, Demple B. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium). Antimicrob Agents Chemother 2001;45:38-43.
12. Pers C, Sogaard P, Pallesen L. Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin. Scand J Infect Dis 1996;28:529-31.
13. Glynn MK, Reddy V, Hutwagner L, Rabatsky-Ehr T, Shiferaw B, Vugia DJ, et al. Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: a FoodNet casecontrol study, 1996-1997. Clin Infect Dis 2004;38:S227-36.
14. Casin I, Breuil J, Darchis JP, Guelpa C, Collatz E. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica Typhimurium isolates in humans. Emerg Infect Dis 2003;9:1455-7.
15. Giraud E, Cloeckaert A, Baucheron S, Mouline C, Chaslus-Dancla E. Fitness cost of fluoroquinolone resistance in Salmonella enterica serovar Typhimurium. J Med Microbiol 2003;52:697-703.
16. Chopra I, O'Neill AJ, Miller K. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat 2003;6:137-45.
17. Maisnier-Patin S, Berg OG, Liljas L, Andersson DI. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimurium. Mol Microbiol 2002;46:355-66.
18. Baucheron S, Chaslus-Dancla E, Cloeckaert A. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J Antimicrob Chemother 2004;53:657-9.
19. Soto SM, Ruiz J, Mendoza MC, Vila J. In vitro fluoroquinolone-resistant mutants of Salmonella enterica serotype Enteritidis: analysis of mechanisms involved in resistance. Int J Antimicrob Agents 2003;22:537-40.
20. Santiviago CA, Toro CS, Hidalgo AA, Youderian P, Mora GC. Global regulation of the Salmonella enterica serovar typhimurium major porin, OmpD. J Bacteriol 2003;185:5901-5.
21. Olliver A, Valle M, Chaslus-Dancla E, Cloeckaert A. Role of an acrR mutation in multidrug resistance of in vitro-selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol Lett 2004;238:267-72.
22. Randall LP, Cooles SW, Sayers AR, Woodward MJ. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. J Med Microbiol 2001;50:919-24.
23. Tibbetts RJ, Lin TL, Wu CC. Phenotypic evidence for inducible multiple antimicrobial resistance in Salmonella choleraesuis. FEMS Microbiol Lett 2003;218:333-8.
24. Piddock LJ, White DG, Gensberg K, Pumbwe L, Griggs DJ. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother 2000;44:3118-21.
25. Gallardo F, Ruiz J, Soto SM, Jimenez de Anta MT, Vila J. Different antibiotic resistance mechanisms associated with integrons in clinical isolates of Salmonella typhimurium. Rev Esp Quimioter 2003;16:398-402.
26. Randall LP, Cooles SW, Osborn MK, Piddock LJ, Woodward MJ. Antibiotic resistance genes, integrons and multiple antibiotic resistance in thirty-five serotypes of Salmonella enterica isolated from humans and animals in the UK. J Antimicrob Chemother 2004;53:208-16.
27. Carattoli A. Plasmid-mediated antimicrobial resistance in Salmonella enterica. Curr Issues Mol Biol 2003;5:113-22.
28. McEwen SA, Fedorka-Cray PJ. Antimicrobial use and resistance in animals. Clin Infect Dis 2002;34 Suppl 3:S93-S106.
29. Angulo FJ, Johnson KR, Tauxe RV, Cohen ML. Origins and consequences of antimicrobial-resistant nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist 2000;6:77-83.
30. Wegener HC, Hald T, Wong DL, Madsen M, Korsgaard H, Bager F, et al. Salmonella control programs in Denmark. Emerg Infect Dis 2003;9:774-80.